The Association between Ambient Carbon Monoxide Levels and Daily Mortality in Toronto, Canada

Journal of the Air and Waste Management Association

Volumn 48, Issue 8, 1998, Pages 689-700

  Burnett, Richard T ^a   Cakmak, Sabit ^a   Raizenne, Mark E ^a   Stieb, David ^a   Vincent, Renaud ^a   Krewski, Daniel ^a   Brook, Jeffrey R ^b   Philips, Owen ^c   Ozkaynak, Haluk ^d  

^a HEALTH CANADA   (Canada)

^b ENVIRONMENT CANADA   (Canada)

^c STATISTICS CANADA   (Canada)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR POLLUTION; DISEASES; HEALTH RISKS; MIXTURES; NITROGEN OXIDES; PARTICLES (PARTICULATE MATTER); SULFUR DIOXIDE;

AIR POLLUTANT; COEFFICIENT OF HAZE; NONACCIDENTAL MORTALITY; SULFATE; TOTAL SUSPENDED PARTICULATE MATTER;

CARBON MONOXIDE;

CARBON MONOXIDE;

AIR POLLUTANT; AIR POLLUTION; AMBIENT AIR; ARTICLE; CANADA; ENVIRONMENTAL MONITORING; HUMAN; MORTALITY; PRIORITY JOURNAL;

EID: 0032142964     PISSN: 10473289     EISSN: None     Source Type: Journal    
DOI: 10.1080/10473289.1998.10463718     Document Type: Article

References (47)

1. Outdoor Air Quality in Toronto: Issues and Concerns. Kenndall, P., Medical Officer of Health; City of Toronto Department of Public Health: Toronto, 1993.
2. Allred, E.N., Bleeker, E.R., Chaitman, B.R., Dahms, T.D., Gottlieb, S.O., Hackney, J.D., Pagana, M., Selverster, R.H., Walden, S.M., Warren, J. “Effects of carbon monoxide on myocardial ishemia,” Environ. Health Perspect. 1991, 91, 89-102.
3. Guyton, A.C. “Transport of oxygen and carbon dioxide in the blood and body fluids.” In Textbook of Medical Physiology, 7th ed., W.B. Saunders: Philadelphia, 1986; pp. 493-503.
4. Burnett, R.T., Brook, J.R., Yung, W.T., Dales, R.E., Krewski, D. “Association between ozone and hospitalization for respiratory diseases in 16 Canadian cities,” Environ. Res. 1997, 72, 24-31.
5. Burnett, R.T., Dales, R.E., Brook, J.R., Raizenne, M.E., Krewski, D. “Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities,” Epidemiol. 1997, 8, 162-167.
6. Lipfert, F.W., Wyzga, R.E. “Air pollution and mortality: Issues and uncertainties,” J. Air & Waste Manage. Assoc. 1995, 45, 949-966.
7. Kinney, P.L., Ito, K., Thurston, G.D. “A sensitivity analysis of mortality/PM10 associations in Los Angeles,” Inhal. Toxicol. 1995, 7, 59-69.
8. Ito, K., Thurston, G.D. “Daily PM10/mortality associations: An investigation of at-risk subpopulations,” J. Expos. Anal. Environ. Epidemiol. 1996, 6, 79-95.
9. Samet, J.M., Zeger, S.L., Kelsall, J.E., Xu, J. Air Pollution and Mortality in Philadelphia, 1974-1988; Report to the Health Effects Institute on Phase 1B: Particle Epidemiology Evaluation Project; Philadelphia, PA, 1997.
10. Gwynn, R.C., Burnett, R.T., Thurston, G.D., submitted for publication in Environ. Health Perspect.
11. Saldiva, P.H.N., Pope, C.A, III; Schwartz, J., Dockery, D.W., Lichtenfels, A.J., Salge, J.M., Barone, I., Bohm, G.M. “Air pollution and mortality in elderly people: A time series study in Sao Paulo, Brazil,” Arch. Environ. Health 1995, 50, 159-163.
12. Touloumi, G., Samoli, E., Katsouyanni, K. “Daily mortality and ‘winter type’ air pollution in Athens, Greece-A time series analysis within the APHEA project,” J. Epidemiol. Comm. Health 1996, 50, S47-S51.
13. Ozkaynak, H., Xue, J., Severance, P., Burnett, R., Raizenne, M. Presented at the Colloquium on Particulate Air Pollution and Human Mortality and Morbidity, Irvine, CA, January 24-25, 1994.
14. Burnett, R.T., Dales, R.E., Raizenne, M.E., Krewski, D., Summers, P.W., Roberts, G.R., Raad-Young, M., Dann, T., Brook, J. “Effects of low ambient levels of ozone and sulfates on the frequency of respiratory admissions to Ontario hospitals,” Environ. Res. 1994, 65, 172-194.
15. Sirois, A., Fricke, W. “Regionally representative daily air concentrations of acid-related substances in Canada, 1983-1987,” Atmos. Environ. 1992, 26A, 593-604.
16. Dann, T. PM10 and PM2.5 Concentrations at Canadian Urban Sites: 1984
17. Environmental Protection Service, Technology Development Directorate, Pollution Measurement Division, Environment Canada: Ottawa, Canada, 1994; PMD 94-3.
18. Ozkaynak, H., Xue, J., Severance, P. Analysis of Associations of Daily Mortality and Air Pollution: Estimation of Daily Fine Particle and Sulfate Concentrations in Toronto Using Airport Visibility and Meteorological Data; Report submitted to Health Canada under Contract No. H4078-2-C684/01-SS; Ottawa, Canada, 1993.
19. Cleveland, W.S., Devlin, S.J. “Robust locally-weighted regression and smoothing scatterplots,” J. Am. Stat. Assoc. 1988, 74, 829-36.
20. Priestly, M.B. Spectral Analysis and Time Series Prediction and Control; Academic Press: New York, 1981.
21. Cakmak, S., Burnett, R., Krewski, D. “Adjusting for temporal variation in the analysis of parallel time series of health and environmental variables,” J. Expos. Anal. Environ. Epidemiol. 1997, 8, 129-144.
22. S-Plus Users Manual; Statistical Sciences inc.: Seattle, WA, 1993.
23. Zidek, J.V., Wong, H., Le, N.D; Burnett, R.T. “Causality, measurement error and multicollinearity in epidemiology,” Environmetrics 1996, 7, 441-451.
24. Akland, G.G., Hartwell, T.D., Johnson, T.R., Whitmore, R.W. “Measuring human exposure to carbon monoxide in Washington, DC, and Denver, Colorado, during the winter of 1982-1983,” Environ. Sci. Technol. 1985, 19, 911-918.
25. Brook, J.R., Wiebe, A.W., Woodhouse, S.W., Audette, C.V., Dann, T.F., Callaghan, S., Piechowski, M., Dabek-Alotorzynska, E., Dloughy, J.F. “Temporal and spatial relationships in fine particle strong acidity, sulphate, PM10, PM2.5 across multiple Canadian locations,” Atmos. Environ. 1997, 47, 2-19.
26. Ozkaynak, H., Xue, J., Zhou, H., Raizenne, M. Associations Between Daily Mortality and Motor Vehicle Pollution in Toronto, Canada; Report submitted to Health Canada, March, 1996. Publication pending.
27. Thurston, G.D. “A critical review of PM10-mortality time-series studies,” J. Expos. Anal. Environ. Epidemiol. 1996, 6, 3-21.
28. Schwartz, J., Dockery, D.W., Neas, L.M. “Is daily mortality associated specifically with fine particles?” J. Air & Waste Manage. Assoc. 1996,10, 927-939.
29. Haldane, J.S. “The action of carbonic oxide on man,” J. Physiol. 1895, 18, 430-462.
30. Douglas, C.G., Haldane, J.S., Haldane, J.B.S. “The laws of combination of haemoglobin with carbon monoxide and oxygen,” J. Physiol. 1912, 44, 275-304.
31. Finkel, A.J. “Carbon Monoxide.” In Hamilton and Hardyes Industrial Toxicology, 4th ed., John Wright-PSG Inc.: Boston, pp. 157-170.
32. Shephard, R.J. Carbon Monoxide. The Silent Killer. Charles C. Thomas: Springfield, 1983.
33. Carbon Monoxide. Environmental Health Criteria 13. World Health Organization: Geneva, 1979.
34. Coburn, R.F., Williams, W.J., White, P., Kahn, S.B. “The production of carbon monoxide from hemoglobin in vivo,” J. Clin. Invest. 1967, 46, 346-356.
35. Coburn, R.F. “The carbon monoxide body stores,” Ann. N.Y. Acad. Sci. 1970, 174, 11-22.
36. Sj’strand, T. “Endogenous formation of carbon monoxide in man under normal and pathological conditions,” Scan. J. Clin. Lab. Invest. 1949, 1, 201-14.
37. Verma, A., Hirsch, D.J., Glatt, C.E., Ronett, G.V., Snyder, S.H. “Carbon monoxide: A putative neural messenger,” Science 1994, 263(5143) 15.
38. Ingi, T., Cheng, J., Ronnett, G.V. “Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system,” Neuron. 1996, 16, 835-842.
39. Fukushima, T., Okinaga, S., Sekizawa, K., Ohrui, T., Yamaya, M., Sasaki, H. “The role of carbon monoxide in lucigenin-dependent chemiluminescence of rat alveolar macrophages,” Eur. J. Pharmacol. 1995, 289, 103-107.
40. Arias-Diaz, J., Vara, E., Garcia, C., Villa, N., Balibrea, J.L. “Evidence for a cyclic guanosine mono phosphate-dependent, carbon monoxide-mediated, signaling system in the regulation of TNF-alpha production by human pulmonary macrophages,” Arch. Surg. 1995, 130, 1287-1293.
41. Giustino, A., Cagiano, R., Carratu, M.R., De Salvia, M.A., Panaro M.A., Jirillo E., Cuomo, V. “Immunological changes produced in rats by prenatal exposure to carbon monoxide,” Pharmacol. Toxicol. 1993, 73, 274-278.
42. Giustino, A., Carratu, M.R., Siro Brigiani, G., De Salvia, M.A., Pellegrino N.M., Steardo, L., Jirillo, E., Cuomo, V. “Changes in the frequency of splenic immune competent cells in rats exposed to carbon monoxide during gestation,” Immunopharmacol. Immunotoxicol. 1994, 16, 281-292.
43. VanUffelen, B.E., de Koster, B.M., VanSteveninck, J., Elferink, J.G. “Carbon monoxide enhances human neutrophil migration in a cyclic GMP-dependent way,” Biochem. Biophys. Res. Comm. 1996, 226, 21-26.
44. Thom, S.R., Ohnishi, S.T., Ischiropoulos, H. “Nitric oxide released by platelets inhibits neutrophil B2 integrin function following acute carbon monoxide poisoning,” Toxicol. Appl. Pharmacol. 1994, 1128, 105-110.
45. Zhang, J., Piantadosi, C.A. “Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain,” J. Clin. Invest. 1992, 90, 1193-1199.
46. Ischiropoulos, H., Beers, M.F., Ohnishi, S.T., Fisher, D., Garner, S.E., Thom, S.R. “Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat,” J. Clin. Invest. 1995, 97, 2260-2267.
47. Thom, S.R. “Leucocytes in carbon monoxide-mediated brain oxidative injury,” Toxicol. Appl. Pharmacol. 1993, 123, 234-247.